ATE64622T1 - Doppelspezifische antikoerper-determinanten. - Google Patents

Doppelspezifische antikoerper-determinanten.

Info

Publication number
ATE64622T1
ATE64622T1 AT85902341T AT85902341T ATE64622T1 AT E64622 T1 ATE64622 T1 AT E64622T1 AT 85902341 T AT85902341 T AT 85902341T AT 85902341 T AT85902341 T AT 85902341T AT E64622 T1 ATE64622 T1 AT E64622T1
Authority
AT
Austria
Prior art keywords
molecules
antibody determinants
determinant
specific antibody
determinants
Prior art date
Application number
AT85902341T
Other languages
English (en)
Inventor
Henry P Paulus
Original Assignee
Boston Biomed Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Biomed Res Inst filed Critical Boston Biomed Res Inst
Application granted granted Critical
Publication of ATE64622T1 publication Critical patent/ATE64622T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT85902341T 1984-04-23 1985-04-22 Doppelspezifische antikoerper-determinanten. ATE64622T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60312584A 1984-04-23 1984-04-23
EP85902341A EP0179872B1 (de) 1984-04-23 1985-04-22 Doppelspezifische antikörper-determinanten
PCT/US1985/000737 WO1985004811A1 (en) 1984-04-23 1985-04-22 Bispecific antibody determinants

Publications (1)

Publication Number Publication Date
ATE64622T1 true ATE64622T1 (de) 1991-07-15

Family

ID=24414191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85902341T ATE64622T1 (de) 1984-04-23 1985-04-22 Doppelspezifische antikoerper-determinanten.

Country Status (11)

Country Link
EP (1) EP0179872B1 (de)
JP (1) JPH0617909B2 (de)
AT (1) ATE64622T1 (de)
AU (1) AU595159B2 (de)
CA (1) CA1338828C (de)
DE (1) DE3583278D1 (de)
DK (1) DK169153B1 (de)
FI (1) FI85946C (de)
IT (1) IT1183798B (de)
NO (1) NO166383C (de)
WO (1) WO1985004811A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987004164A1 (en) * 1986-01-06 1987-07-16 The University Of Melbourne Technetium-antibody conjugate
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
FR2608445B1 (fr) * 1986-12-19 1989-04-21 Muraour Renaud Embout pour manche de raquette de tennis et autres similaires, et raquette equipee de cet embout
EP0301333A3 (de) * 1987-07-29 1992-07-01 Abbott Laboratories Auf liposomen basierter, homogener Immunoassay für diagnostische Teste
US4971916A (en) * 1987-07-29 1990-11-20 Abbott Laboratories Liposome based homogeneous immunoassay for diagnostic tests
US5086002A (en) * 1987-09-07 1992-02-04 Agen Biomedical, Ltd. Erythrocyte agglutination assay
OA08953A (fr) * 1987-09-17 1990-11-30 Agen Ltd Agglutination assay
FI105320B (fi) * 1988-04-04 2000-07-31 Oncogen Menetelmä vasta-aineheterokonjugaattien valmistamiseksi, joita käytetään imusoluaktiivisuuden säätelyssä ja diagnoosissa
US6010902A (en) * 1988-04-04 2000-01-04 Bristol-Meyers Squibb Company Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
SE8804074D0 (sv) * 1988-11-10 1988-11-10 Pharmacia Ab Sensorenhet och dess anvaendning i biosensorsystem
IT1235349B (it) * 1988-12-23 1992-06-30 Biodata Spa Saggio immunologico per determinazioni in fase omogenea
US5583003A (en) * 1989-09-25 1996-12-10 Agen Limited Agglutination assay
TW212184B (de) * 1990-04-02 1993-09-01 Takeda Pharm Industry Co Ltd
ES2583079T3 (es) * 2006-09-21 2016-09-19 Nestec S.A. Matrices a base de anticuerpos para detectar transductores de señales múltiples en células de rara circulación

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4233402A (en) * 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
AU531777B2 (en) * 1978-04-05 1983-09-08 Syva Co. Label/solid conjugate immunoassay system
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4433859A (en) * 1981-07-16 1984-02-28 Nl Industries, Inc. Wellhead connector with release mechanism
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
US4520110A (en) * 1981-10-06 1985-05-28 The Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing a phycobiliprotein labeled ligand or receptor
EP0076695B1 (de) * 1981-10-06 1985-02-20 The Board Of Trustees Of The Leland Stanford Junior University Fluoreszierende Konjugate zum Analysieren von Molekülen und Zellen
ES8504461A1 (es) * 1982-04-12 1985-04-16 Hybritech Inc Un procedimiento para obtener un polidoma.
CA1194415A (en) * 1982-05-05 1985-10-01 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4446233A (en) * 1982-05-05 1984-05-01 E. I. Du Pont De Nemours And Company Homogeneous immunoassay using covalent hybrid antibodies

Also Published As

Publication number Publication date
NO166383B (no) 1991-04-02
EP0179872A1 (de) 1986-05-07
EP0179872A4 (de) 1988-12-22
EP0179872B1 (de) 1991-06-19
CA1338828C (en) 1997-01-07
JPS61501418A (ja) 1986-07-10
DK601985A (da) 1985-12-23
IT1183798B (it) 1987-10-22
WO1985004811A1 (en) 1985-11-07
DK601985D0 (da) 1985-12-23
NO855200L (no) 1985-12-20
IT8567383A0 (it) 1985-04-23
NO166383C (no) 1991-07-10
DE3583278D1 (de) 1991-07-25
FI85946B (fi) 1992-03-13
DK169153B1 (da) 1994-08-29
IT8567383A1 (it) 1986-10-23
AU595159B2 (en) 1990-03-29
JPH0617909B2 (ja) 1994-03-09
FI85946C (fi) 1992-06-25
AU4290185A (en) 1985-11-15
FI855086L (fi) 1985-12-19
FI855086A0 (fi) 1985-12-19

Similar Documents

Publication Publication Date Title
ATE64622T1 (de) Doppelspezifische antikoerper-determinanten.
ATE21932T1 (de) Bispezifische antikoerperdeterminanten.
DK450183D0 (da) Humane monoklone antistoffer mod et bakterietoksin samt disses fremstilling, kontinuerlige cellelinier, som producerer antitoksinantistoffer, samt antistoffernes anvendelser
DE3580654D1 (de) Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.
ES2124250T3 (es) Anticuerpo especifico para un antigeno tumoral.
FI853283A7 (fi) Uudet monoklonaaliset glykokonjugaattien vasta-aineet, menetelmät niiden tuottamiseksi, ja niiden käytöt.
FR2437937A1 (fr) Membrure d'ame de panneau composite et son procede de fabrication
ES531636A0 (es) Procedimiento de fabricacion de una cuerda compuesta
DE3751182D1 (de) Monoklonale Antikörper, B-spezifisch für Apolipoprotein, die von zwei Hybridomen erzeugt werden.
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
IT8449292A0 (it) Linfochina,anticorpo monoclonale specifico per tale linfochina,e procedimento per la loro produzione
FR2601679B1 (fr) Immunotoxines, procede de preparation et compositions pharmaceutiques en contenant
DE3583296D1 (de) Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung.
DE3850993D1 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.
FI832765A7 (fi) Laipoitettu, muovilla vuorattu putki ja sen valmistusmenetelmä.
ES541574A0 (es) Un metodo para producir una hidrioma de ser humano.ser humano productor de anticuerpos antitetanicos.
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
DE3579808D1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
PT98706A (pt) Linhas celulares de hibridoma anticorpos monoclonais contra leptosphaeria produzidos por elas e metodos para a sua producao e utilizacao
UA41926C2 (uk) Прокат бульбоподібного профілю та спосіб його виготовлення
EP0622082A4 (de) Immunkomplex.
FI893427A7 (fi) Monoklonaalinen vasta-aine, joka pystyy tunnistamaan gangliosideja GQ1b ja GT1a, sitä tuottava hybridooma sekä menetelmä hybridooman valmistamiseksi
JPS5259875A (en) Transmission line and its forming method
FR2483502B1 (fr) Attache notamment pour l'assemblage de meubles, son procede de fabrication, et son application a la realisation d'une charniere
KR860001184A (ko) Pta-210 세포주를 이용한 인간성장 호르몬의 생산방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee